Connection
Ashley Frazer-Abel to Complement Inactivating Agents
This is a "connection" page, showing publications Ashley Frazer-Abel has written about Complement Inactivating Agents.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.339 |
|
|
|
-
Rizk DV, Dixon BP, Chan M, Cook HT, Frazer-Abel A, Tang SCW. Biomarkers in the Management of Complement-Mediated Kidney Diseases in the Era of Complement Therapeutics. Clin J Am Soc Nephrol. 2026 Jul 01; 21(7):1245-1257.
Score: 0.216
-
Thurman JM, Frazer-Abel A, Holers VM. The Evolving Landscape for Complement Therapeutics in Rheumatic and Autoimmune Diseases. Arthritis Rheumatol. 2017 11; 69(11):2102-2113.
Score: 0.123